Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NHL repeat-containing protein 3 (NHLRC3) is a protein encoded by the NHLRC3 gene, and contains distinctive NCL-1, HT2A, and Lin-41 (NHL) protein family repeats[1][2][3][7]. NHL-repeat containing proteins in mammals are predicted to function primarily in enzymatic processes, in particular protein modification such as ubiquitination, through their putative ubiquitin-protein ligase activity[4][5][6]. NHLRC3 is listed as a protein-coding gene and displays alternative splicing, but there is currently no experimental evidence for a direct role in human disease, nor is it considered a validated therapeutic target[2][7]. Its functional associations include predicted involvement in the innate immune system and protein catabolism, but specific biological or clinical applications remain undefined[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NHL repeat-containing protein 3 (NHLRC3).